Articles

Targeting metabolism and survival in chronic lymphocytic leukemia and Richter syndrome cells by a novel NF-κB inhibitor

Department of Medical Sciences, University of Turin, Italy;Italian Institute for Genomic Medicine, Turin, Italy
Department of Medical Sciences, University of Turin, Italy;Italian Institute for Genomic Medicine, Turin, Italy
ImmuneTarget Inc., San Diego, CA, USA
Italian Institute for Genomic Medicine, Turin, Italy
Department of Molecular Biotechnologies and Health Sciences, University of Turin, Italy
Department of Medical Sciences, University of Turin, Italy;Italian Institute for Genomic Medicine, Turin, Italy
Italian Institute for Genomic Medicine, Turin, Italy
Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA
ImmuneTarget Inc., San Diego, CA, USA
CLL Research Center, New York Presbyterian Hospital, Weill Cornell Medicine, New York, NY, USA
CLL Research Center, New York Presbyterian Hospital, Weill Cornell Medicine, New York, NY, USA
Department of Medical Sciences, University of Turin, Italy;Italian Institute for Genomic Medicine, Turin, Italy
Vol. 102 No. 11 (2017): November, 2017 https://doi.org/10.3324/haematol.2017.173419